It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CHE’s FA Score shows that 0 FA rating(s) are green whileHCA’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CHE’s TA Score shows that 5 TA indicator(s) are bullish while HCA’s TA Score has 4 bullish TA indicator(s).
CHE (@Medical/Nursing Services) experienced а +4.30% price change this week, while HCA (@Medical/Nursing Services) price change was -7.42% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.10%. For the same industry, the average monthly price growth was +0.83%, and the average quarterly price growth was -0.20%.
CHE is expected to report earnings on Oct 29, 2025.
HCA is expected to report earnings on Oct 17, 2025.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
CHE | HCA | CHE / HCA | |
Capitalization | 9.7B | 88.2B | 11% |
EBITDA | 414M | 12.7B | 3% |
Gain YTD | -10.992 | 11.853 | -93% |
P/E Ratio | 35.73 | 17.40 | 205% |
Revenue | 2.26B | 65B | 3% |
Total Cash | 264M | 935M | 28% |
Total Debt | 155M | 41.9B | 0% |
CHE | HCA | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 6 | 57 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 85 Overvalued | 4 Undervalued | |
PROFIT vs RISK RATING 1..100 | 83 | 19 | |
SMR RATING 1..100 | 37 | 42 | |
PRICE GROWTH RATING 1..100 | 87 | 59 | |
P/E GROWTH RATING 1..100 | 74 | 73 | |
SEASONALITY SCORE 1..100 | 50 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HCA's Valuation (4) in the Hospital Or Nursing Management industry is significantly better than the same rating for CHE (85) in the Medical Or Nursing Services industry. This means that HCA’s stock grew significantly faster than CHE’s over the last 12 months.
HCA's Profit vs Risk Rating (19) in the Hospital Or Nursing Management industry is somewhat better than the same rating for CHE (83) in the Medical Or Nursing Services industry. This means that HCA’s stock grew somewhat faster than CHE’s over the last 12 months.
CHE's SMR Rating (37) in the Medical Or Nursing Services industry is in the same range as HCA (42) in the Hospital Or Nursing Management industry. This means that CHE’s stock grew similarly to HCA’s over the last 12 months.
HCA's Price Growth Rating (59) in the Hospital Or Nursing Management industry is in the same range as CHE (87) in the Medical Or Nursing Services industry. This means that HCA’s stock grew similarly to CHE’s over the last 12 months.
HCA's P/E Growth Rating (73) in the Hospital Or Nursing Management industry is in the same range as CHE (74) in the Medical Or Nursing Services industry. This means that HCA’s stock grew similarly to CHE’s over the last 12 months.
CHE | HCA | |
---|---|---|
RSI ODDS (%) | 2 days ago55% | 2 days ago69% |
Stochastic ODDS (%) | 2 days ago52% | 2 days ago73% |
Momentum ODDS (%) | 2 days ago50% | 2 days ago60% |
MACD ODDS (%) | 2 days ago56% | 2 days ago41% |
TrendWeek ODDS (%) | 2 days ago51% | 2 days ago58% |
TrendMonth ODDS (%) | 2 days ago45% | 2 days ago56% |
Advances ODDS (%) | 4 days ago48% | 26 days ago71% |
Declines ODDS (%) | 6 days ago48% | 2 days ago57% |
BollingerBands ODDS (%) | 2 days ago53% | 2 days ago74% |
Aroon ODDS (%) | 2 days ago29% | 2 days ago56% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PRF | 43.34 | 0.16 | +0.37% |
Invesco RAFI US 1000 ETF | |||
PBFR | 27.98 | 0.04 | +0.13% |
PGIM Laddered S&P 500 Buffer 20 ETF | |||
BSMU | 21.49 | 0.01 | +0.07% |
Invesco BulletShares 2030 Muncpl Bd ETF | |||
IBBQ | 22.73 | 0.01 | +0.06% |
Invesco Nasdaq Biotechnology ETF | |||
IYZ | 29.97 | -0.31 | -1.01% |
iShares US Telecommunications ETF |
A.I.dvisor indicates that over the last year, HCA has been closely correlated with THC. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if HCA jumps, then THC could also see price increases.
Ticker / NAME | Correlation To HCA | 1D Price Change % | ||
---|---|---|---|---|
HCA | 100% | -2.10% | ||
THC - HCA | 71% Closely correlated | +3.13% | ||
UHS - HCA | 63% Loosely correlated | +0.09% | ||
CYH - HCA | 50% Loosely correlated | -4.48% | ||
ENSG - HCA | 49% Loosely correlated | +8.92% | ||
SGRY - HCA | 41% Loosely correlated | +1.19% | ||
More |